ABSTRACT
Background The role of health-related disparities including sociodemographic, environmental, and critical care capacity in the COVID-19 pandemic are poorly understood. In the present study, we characterized vulnerable populations located in areas at higher risk of COVID-19 related mortality and low critical healthcare capacity in the U.S.
Methods Using Bayesian multilevel analysis and small area disease risk mapping, we assessed the spatial variation of COVID-19 related mortality risk for the U.S. in relation with healthcare disparities including race, ethnicity, poverty, air quality, and critical healthcare capacity.
Results Overall, highly populated, regional air hub areas, and minorities had an increased risk of COVID-19 related mortality. We found that with an increase of only 1 ug/m3 in long term PM2.5 exposure, the COVID-19 mortality rate increased by 13%. Counties with major air hubs had 18% increase in COVID-19 related death compared to counties with no airport connectivity. Sixty-eight percent of the counties with high COVID-19 related mortality risk were also counties with lower critical care capacity than national average. These counties were primary located at the North- and South-Eastern regions of the country.
Conclusion The existing disparity in health and environmental risk factors that exacerbate the COVID-19 related mortality, along with the regional healthcare capacity, determine the vulnerability of populations to COVID-19 related mortality. The results from this study can be used to guide the development of strategies for the identification and targeting preventive strategies in vulnerable populations with a higher proportion of minority groups living in areas with poor air quality and low healthcare capacity.
Question What are the sociodemographic and environmental drivers of the heterogeneous distribution of the COVID-19 related mortality in the U.S., and what are the vulnerable areas at higher risk of COVID-19 related mortality and low critical healthcare capacity?
Findings Higher proportions of African American and Latino populations, as well as high levels of air pollution and airport connectivity were linked to higher risk of COVID-19 related mortality. Over 68% of the counties with high COVID-19 related mortality risk were also counties with lower critical care capacity than national average.
Meaning In a time-limited response, the identification and targeting prevention efforts should focus in vulnerable populations located in high risk areas in which sociodemographic and environmental factors are exacerbating the burden of COVID-19 related deaths.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH NHLBI award R01HL132344 and NIEHS award P30ES006096 From Center for Environmental Genetics (CEG), Department of Environmental and Public Health Sciences, University of Cincinnati.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data that support the findings of this study are openly available from the Johns Hopkins University Center for Systems Science and Engineering through a GitHub repository (https://github.com/CSSEGISandData/COVID-19). Therefore, our study did not require an ethics approval because there were no human participants involved in this research, and it relies entirely on previously published data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are openly available from the Johns Hopkins University Center for Systems Science and Engineering through a GitHub repository (https://github.com/CSSEGISandData/COVID-19).
